Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-09-25
Item 5.02
Diane E. Offereins was appointed to Navient's Board of Directors effective September 24, 2026, upon recommendation of the Nominations and Governance Committee. She brings 35+ years of financial services experience and expertise in executive compensation, information technology, and cybersecurity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-25
Item 3.02
BlackRock Private Credit Fund disclosed an unregistered sale of 107,475.86 Institutional Class Shares for $2,540,654 to feeder vehicles, exempt under Section 4(a)(2) and Regulation S, increasing share count and diluting existing holders' ownership interests.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-25
Item 8.01
BlackRock Private Credit Fund declared a regular distribution on September 24, 2026, specifying per-share distribution amounts for Institutional, Class S, and Class D shares, with payment scheduled for October 28, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-25
Item 5.07
This Item 5.07 disclosure reports the results of a special meeting of stockholders held on September 24, 2026, where shareholders voted on two proposals: approval of stock issuance upon conversion of 5.00% Senior Convertible Notes due 2033 (Proposal 1, which passed with 51,188,980 votes for vs. 5,175,849 against) and approval of adjournment if needed (Proposal 2). The filing directly states voting results with vote counts, meeting date, record date, and quorum information, which is the core content of Item 5.07 shareholder vote results disclosures. The approval of convertible note conversion is material to investors as it affects share dilution and capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-25
Item 5.02
The filing discloses both the resignation of Patrick Wolfe as COO (effective December 18, 2026) and the appointment of Dan Worrell as COO (also effective December 18, 2026). While both events occur, the principal action disclosed is the appointment of Worrell to the COO role, with detailed biographical information and his qualifications as a Managing Director of BlackRock and former Co-Chief Investment Officer. The appointment of a new COO is material to investors assessing the company's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-25
Item 5.02
The filing discloses both the resignation of Patrick Wolfe as COO (effective December 18, 2026) and the appointment of Dan Worrell as COO (also effective December 18, 2026). While both events are disclosed, the principal action emphasized in the Item 5.02 structure and the Board's deliberate appointment decision centers on Worrell's appointment to the COO role. The appointment of a new COO is material to investors as it represents a change in senior executive leadership responsible for operational oversight.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 93%
filed 2026-09-25
EX-99.1
Hafnia Limited successfully completed a registered public offering of 35,488,875 ordinary shares, raising approximately USD 300 million in gross proceeds. The offering was executed pursuant to a prospectus supplement filed under an effective Form F-3 shelf registration statement, with legal opinions confirming the transaction structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-09-25
Item 1.01
DICK'S Sporting Goods entered into an underwriting agreement on September 22, 2026 to issue $1 billion in senior notes ($400 million due 2036 at 6.200% and $600 million due 2056 at 6.900%). This is a material debt issuance creating new direct financial obligations governed by an indenture with a trustee. The company explicitly states the notes are "unsecured, unsubordinated obligations" and intends to use proceeds for general corporate purposes including debt repayment and share repurchases.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-25
Item 5.02
The filing discloses both the resignation of Patrick Wolfe as COO (effective December 18, 2026) and the appointment of Dan Worrell as COO (also effective December 18, 2026). While both events are disclosed, the principal action emphasized in the Item 5.02 structure and the Board's deliberate appointment decision centers on Worrell's appointment to the COO role. The appointment of a senior executive to a C-suite position is material to investors' assessment of company leadership and governance.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-25
Item 1.01
The company entered into a Fourth Amendment to the Shareholders Rights Agreement, extending the rights plan's expiration date and revising qualifying offer provisions. The Board's decision was informed by shareholder advisory vote and feedback.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-25
EX-99.1
Addex has regained full global rights to its GABAB positive allosteric modulator portfolio from Indivior following Indivior's R&D rationalization and planned merger with Supernus Pharmaceuticals. This represents a material change in the company's asset portfolio and intellectual property rights—the return of a development candidate for substance use disorders plus freedom to pursue additional therapeutic indications. The CEO explicitly states this gives Addex "the flexibility to advance our broader GABAB PAM portfolio independently" and "one of the broadest portfolios targeting GABAB receptor biology," indicating a significant strategic repositioning of the company's pipeline and competitive position.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-09-25
EX-99.1
This is a press release announcing five-year follow-up clinical trial data for CARVYKTI (cilta-cel), Legend Biotech's lead therapeutic product. The disclosure presents material clinical efficacy and safety results from the CARTITUDE-2 Cohort A study, including a 50% progression-free survival rate at five years and 69.2% overall survival, which are significant outcomes for a cell therapy product. While this is not a financial earnings release in the traditional sense, it is a material clinical milestone announcement that would substantially affect investor assessment of the company's product pipeline and commercial prospects. The data directly supports the therapeutic potential and market value of the company's primary revenue-generating asset.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-25
EX-99.1
The exhibit announces that Alpha Compute has regained compliance with Nasdaq Listing Rule 5550(a)(2) after receiving a deficiency notice on March 2, 2026 for failing to maintain a minimum closing bid price of $1.00 per share. This is a material delisting-risk disclosure: the company faced a concrete threat of delisting due to non-compliance with continued listing standards, and the announcement confirms resolution of that threat. The language "regained compliance" and "the matter is now closed" directly address the prior delisting risk.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-25
Item 7.01
The filing discloses Board approval of a quarterly cash dividend of $0.33 per Class A share and $0.30 per Class B share, payable October 23, 2026 to shareholders of record on October 9, 2026. This is a straightforward dividend declaration, which is a material event affecting shareholder returns and capital allocation decisions.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-25
The filing discloses a $3.6 million order for Hyperboloid connectors for medical defibrillator applications, representing IEH's strategic expansion into the medical market alongside its defense business. While the press release is attached as Exhibit 99.1 under Item 9.01, the core event is a material commercial order/contract win in a new market segment, which does not fit the specific operational categories (workforce reduction, restructuring) but clearly represents a significant operational and strategic development for the company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-25
Item 5.07
This is a clear disclosure of shareholder vote results under Item 5.07. The filing reports the outcomes of two proposals voted on at an extraordinary general meeting on September 23, 2026: an Authorized Share Capital Increase Proposal (rejected 75.4% against) and a Reverse Share Split Proposal (rejected 74.1% against). Both proposals failed to achieve majority approval. The rejection of these capital structure proposals is material to investors as it affects the Company's ability to execute planned financing or restructuring strategies.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-09-25
Item 3.01
Silexion received a formal notice from Nasdaq on September 25, 2026, that its ordinary shares have failed to maintain the minimum $1.00 bid price required under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days. The Nasdaq hearings panel will consider whether to allow the company to remain listed on the Nasdaq Capital Market. This is a classic delisting risk disclosure under Item 3.01, materially threatening the company's continued exchange listing.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-25
EX-99.1
IM Cannabis closed a registered direct offering of 655,000 common shares at US$2.00 per share, raising US$1.31 million in gross proceeds. This is a registered equity issuance to accredited investors under an effective Form F-3 shelf registration statement. The disclosure explicitly notes the Company was in "serious financial difficulty" and relied on MI 61-101 exemptions based on financial hardship, indicating material dilution to existing shareholders and capital-raising necessity typical of small-cap issuers under financial stress.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-25
The filing discloses an updated investor presentation related to a Business Combination Agreement between Blue Acquisition Corp., Blockfusion USA, Inc., and Blockfusion Digital Infrastructure, Inc. (Pubco), with multiple amendments through September 21, 2026. The transaction contemplates Blue and Blockfusion becoming wholly-owned subsidiaries of Pubco, which will become a publicly traded company. This constitutes a material acquisition/merger activity requiring disclosure under Item 7.01 (Regulation FD Disclosure) as a written communication under Rule 425.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-09-25
EX-99.1
The exhibit is a Director Offer Letter dated September 22, 2026, appointing Chunhui Zhu as an Independent Director, Chairperson of the Audit Committee, and member of the Compensation and Nominating & Corporate Governance Committees. This is a clear appointment of a director to multiple governance roles, which is a material event affecting the registrant's board composition and governance structure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 78%
filed 2026-09-25
EX-99.2
Bilibili scheduled an extraordinary general meeting for October 28, 2026, to seek shareholder approval for a material transaction involving the repurchase of 13,591,090 Class Z ordinary shares (including ADSs) for US$200 million from Tencent subsidiaries, coupled with Tencent's concurrent subscription for US$200 million of convertible senior notes due 2031.
View raw filing on EDGAR →
8-K
Operational Other
confidence 74%
filed 2026-09-25
Item 8.01
Atlas Energy Solutions entered into equipment purchase agreements and cost reimbursement agreements with a frontier AI lab to secure 283 MW of Caterpillar natural gas generation capacity and supporting infrastructure for data center projects, with customer-backed financing arrangements that de-risk supply chain and project timelines.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-25
Item 8.01
This disclosure announces the effectiveness of Vylor's Form 10 registration statement and the imminent completion of a separation of Vylor into an independent, publicly traded company expected on October 1, 2026. The separation constitutes a material change of control and disposition event—Corteva is divesting a significant business segment (an advanced seed and genetics company) and distributing it to shareholders. This is a material M&A/corporate restructuring activity that would substantially affect investor assessment of both Corteva and the newly independent Vylor.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-25
Item 8.01
This disclosure announces the effectiveness of Vylor's Form 10 registration statement and the imminent completion of a separation of Vylor from its parent company Corteva, expected October 1, 2026. The separation involves a pro-rata distribution of Vylor shares to Corteva stockholders and Vylor's listing on NYSE under ticker "VYLR." This constitutes a material change of control and corporate restructuring event—a spin-off or separation that fundamentally alters the registrant's corporate structure and ownership, meeting the definition of ma_activity under Items 1.01/2.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-25
Item 8.01
The disclosure reports receipt of the final regulatory approvals and waivers required to complete a merger of First Seacoast Bancorp into Cambridge Financial Group, with closing expected October 1, 2026. This constitutes a material acquisition/change of control event—the company is being merged into another entity, representing a fundamental transformation of the registrant. The stockholder approval on August 27, 2026 and imminent closing date confirm this is a completed or near-completion M&A transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 45%
filed 2026-09-25
Item 8.01
This disclosure announces a special meeting of stockholders scheduled for October 28, 2026, to vote on proposed amendments to preferred stock certificates of designations that would change dividend payment frequency from periodic to daily. While the filing is technically Item 8.01 (Other Events) rather than Item 5.07, the core event is a stockholder vote on material preferred stock terms. However, this is a pre-vote announcement rather than a results disclosure, creating ambiguity about whether to classify as shareholder_vote_results or operational_other.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-25
Item 7.01
McGraw Hill announced a proposed offering of $500 million in senior secured notes due 2033, together with amendments to credit facilities including a new $830 million term loan B facility and extension of revolving credit facilities. The proceeds are to be used to redeem existing 2028 notes and refinance existing term loans, constituting a material refinancing of the company's capital structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-09-25
Item 8.01
The Company entered into an underwriting agreement on September 21, 2026 for the sale of $300,000,000 aggregate principal amount of First Mortgage Bonds due 2056 at 6.15%. This is a material creation of a new direct financial obligation under Item 2.03 (or disclosed under Item 8.01 as here), representing a significant debt issuance that would affect investor assessment of the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 80%
filed 2026-09-25
Item 1.01
Galaxy Gaming amended its existing Credit Agreement with BMO Bank N.A., increasing capital expenditure limitations and approving an EBITDA addback for covenant compliance purposes. This material modification of the Company's borrowing terms and direct financial obligations suggests the Company was managing covenant compliance risk.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-25
Item 8.01
The Board of Trustees declared a regular monthly dividend of $0.24 per share to common shareholders, payable on or before October 30, 2026. This is a straightforward dividend distribution disclosure, material to investors as it affects shareholder returns and the fund's capital allocation policy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-25
Item 3.02
Silver Point Private Credit Fund conducted an unregistered sale of 902,356 common shares for $24.3 million at $26.94 per share pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-25
Item 8.01
The Board of Trustees declared a regular monthly dividend of $0.1575 per share payable on or before October 30, 2026, to shareholders of record as of September 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-25
Item 1.01
First Merchants Corporation entered into an Indenture to issue $100 million aggregate principal amount of 6.750% Fixed-to-Floating Rate Subordinated Notes due 2036, representing a material creation of a direct financial obligation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-25
Item 5.07
This Item 5.07 filing discloses the results of a special shareholder meeting held on September 23, 2026, where shareholders voted to approve a Merger Agreement between MPCF and JHCPIF. The vote results (8,256,379.591 votes for, 0 against, 0 abstain) represent shareholder approval of a material acquisition/merger transaction. This is a classic shareholder_vote_results disclosure, and the underlying merger is material to investors.
View raw filing on EDGAR →
8-K
Material Impairment
confidence 75%
filed 2026-09-25
Item 8.01
BCB Bancorp announced the sale of approximately $205.3 million in problem loan portfolios with an estimated pre-tax loss of $43.3 million to be recorded in Q3 2026. While this is technically a loan sale (asset disposition), the disclosure centers on the material charge/write-down associated with the sale of criticized and classified loans, which is the economically significant event. The $43.3 million loss represents a substantial impairment charge that will materially impact Q3 results.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-25
Item 3.02
Apollo Infrastructure Co LLC completed an unregistered private placement of approximately $68.1 million in equity securities across multiple share classes (Series I and Series II A-II, F-I, E, and I Shares) to third-party investors, issuing over 2.2 million shares under Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-25
Item 2.02
Worthington Enterprises disclosed unaudited financial results for the first quarter of fiscal 2027 ended August 31, 2026, presented via conference call on September 23, 2026, including detailed financial tables reconciling GAAP net earnings to adjusted EBITDA, free cash flow metrics, and segment performance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-25
Item 5.02
The Compensation Committee approved a special leadership retention performance share award of 150,000 Performance Shares to Joseph B. Hayek, President and CEO, on September 21, 2026, subject to performance-based and time-based vesting conditions tied to stock price and continued employment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-25
Item 5.07
Worthington Enterprises held its Annual Meeting on September 22, 2026, with shareholders voting on and approving three proposals: election of three directors (Chiappone, Southern, and Standridge), advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-25
Item 5.02
Lucibeth N. Mayberry was appointed as President, CEO, and Director of CoreCivic, effective September 24–25, 2026, following the resignation of Patrick D. Swindle due to health reasons. Mayberry, who has served the company for 23 years including as Executive Vice President and Chief Strategy Officer, assumes leadership with detailed compensation terms and strategic continuity emphasized.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-25
Item 5.02
The filing discloses both a director departure (Edward M. Kaye's resignation effective September 23, 2026) and a director appointment (Alexander Bo Cumbo appointed to the Board as a Class III director on the same date). While both events occurred, the principal disclosed action centers on the appointment of Cumbo to fill the vacancy, supported by detailed disclosure of his compensation (annual cash retainer of $45,000 and an initial stock option grant valued at approximately $724,000). The appointment is material as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-25
Item 1.01
Oaktree Gardens entered into a third amendment to its revolving credit agreement on September 21, 2026, which extended the maturity date to September 23, 2027 (with extension options through 2031), reduced the interest rate, and modified the unused commitment fee. This material modification of an existing direct financial obligation affects the Company's capital structure and debt terms.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-25
Item 8.01
The filing discloses the declaration of regular and special distributions for Class I and Class S common shares, with specific per-share amounts ($0.21 and $0.19125 net, respectively), a record date of September 30, 2026, and a payment date of October 30, 2026. This is a routine but material dividend declaration typical of closed-end funds, affecting shareholder returns and reinvestment decisions.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-25
Item 1.01
Enova's subsidiary ODAS IV issued $500,026,000 in fixed-rate asset-backed notes (Series 2026-1 Notes) on September 25, 2026, secured by a pool of small business loans, with four note classes, fixed interest coupons ranging from 5.61% to 8.28%, and final maturity in October 2032. This represents a material creation of a direct financial obligation through a securitization facility.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-25
Item 3.02
The Fund sold 192,455 unregistered Class I common shares to feeder vehicles for $5.0 million, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-25
Item 7.01
The Fund declared both a regular distribution of $0.1875 per Class I Share and a special distribution of $0.0300 per Class I Share, payable to shareholders of record as of September 30, 2026, with payment on or about October 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-09-25
Item 2.03
Ashland amended and restated its European accounts receivable securitization facility, extending the termination date to September 21, 2029, and maintaining a €125 million aggregate facility limit. The amendment involves Bank of America entities and updates to market-standard terms, representing a material refinancing and extension of a direct financial obligation affecting the company's liquidity and capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-25
Item 5.02
The filing discloses the appointment of Jean-Marc Germain as a director of Pool Corporation effective September 30, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The Board was expanded from eight to nine directors to accommodate this appointment. Germain is a seasoned executive with significant leadership experience (former CEO of Constellium SE and Algeco Scotsman Global) and current public company board service, making this a material governance event affecting the composition and expertise of the Board.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-25
Item 2.03
SBA Communications established a $2.5 billion commercial paper program on September 25, 2026, creating a new direct financial obligation under Item 2.03. The disclosure describes the creation of short-term unsecured notes with maturities up to 397 days, dealer agreements, and terms for issuance in the U.S. commercial paper market. This is a material debt facility establishment that would affect investor assessment of the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-25
Item 8.01
This Item 8.01 discloses the completion and imminent consummation of a material spin-off separation. The filing announces that the SEC declared the Registration Statement effective on September 24, 2026, and that the Distribution of Vylor common stock to Corteva stockholders is expected to occur on October 1, 2026, with Vylor common stock expected to begin trading on the NYSE under symbol "VYLR." This constitutes a material change of control and separation transaction—a spin-off is a form of ma_activity involving the separation of a business segment into an independent publicly traded company.
View raw filing on EDGAR →